Advera Health Analytics, Inc.'s interests
Advera Health Analytics, Inc.'s posts
Post has attachment
Check out our latest alert on Bevyxxa, which was recently approved for the treatment of venous thromboembolism http://hubs.ly/H082Zk70
Post has attachment
Canada's March Toward Mandatory Reporting of Adverse Events by Providers http://hubs.ly/H0838Qf0
Post has attachment
Happy (Drug Safety Data) Independence Day http://hubs.ly/H07Yr220
Post has attachment
Analysis of Keytruda label and adverse event data regarding recent indication approvals http://hubs.ly/H07VTmG0
Post has attachment
Evidex Alert | New analysis available on Puma’s Nerlynx http://hubs.ly/H07M6fF0
Post has attachment
Failure to Warn: The Week in Drug Safety News http://hubs.ly/H07M6Sn0
Post has attachment
Great investigative journalism by Stat News on safety concerns for Acterma for Rheumatoid Arthritis - Advera provided support with data extracted from Evidex http://hubs.ly/H07JV520
Post has attachment
How is Evidex Different from Traditional Signal Detection Software? http://hubs.ly/H07CX8k0
Post has attachment
Download a copy of #ISPORBoston poster presentation on downstream medical costs for TNFa Inhibitors http://hubs.ly/H07wBqs0
Post has attachment
Post-Marketing Drug Safety and Pharmacovigilance Is Now More Important Than Ever http://hubs.ly/H07tQ8b0
Wait while more posts are being loaded





